Akeso Inc. (AKESF)
OTC
Closed
Aug 21, 2026
Day's Range
11.5052 wk Range
10.50Overview - AKESF - Akeso Inc.
Key Statistics
Valuation
Enterprise Value
873.64M
P/E (Trailing)
‪25.67‬
Price / Sales (TTM)
‪3.46‬
Price / Book
‪7.87‬
EV / EBITDA
‪-7.80‬
Profitability
Profit Margin
‪-36.41%‬
Operating Margin
‪-30.66%‬
Return on Assets
‪-4.32%‬
Return on Equity
‪-14.53%‬
Ownership
Shares Outstanding
921.14M
Float
721.54M
Held by Insiders
‪21.66%‬
Held by Institutions
‪32.51%‬
Price stats
Beta
‪0.02‬
50-Day Avg
‪11.91‬
200-Day Avg
‪14.28‬
Dividends
Payout Ratio
‪0.00%‬
Shariah Compliance
Report Date: Feb 20, 2025
Screened by Zoya using the AAOIFI methodology.
Market Cap - AKESF - Akeso Inc.
Peers - AKESF - Akeso Inc.
Peer Comparison
Compared with companies in Biotechnology listed on OTC.
Profile Summary - AKESF - Akeso Inc.
About
Akeso Inc. is a biotechnology company primarily dedicated to the development of innovative antibody-based therapies. Focused on cutting-edge biopharmaceutical research, Akeso Inc. plays a pivotal role in the healthcare sector, particularly within oncology and immunology. The company leverages proprietary technology…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Shariah compliance data provided by Zoya. Charting by TradingView.
Last updated:
